The Countering Chinese Cyberthreats for Patients Act mandates a review of medical devices made in China for cybersecurity risks.
The Countering Chinese Cyberthreats for Patients Act requires the Secretary of Health and Human Services to review certain medical devices manufactured in China for potential cybersecurity issues. The Secretary must request information from covered manufacturers, including software components and data mapping. If a cybersecurity risk is identified, the Secretary can order the cessation of distribution and use of the device. The Act also mandates a report on the cyber preparedness of the device industry in the United States and recommendations to bolster cybersecurity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.